Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion description "[In the present study, we investigated whether the hypolipidemic drug bezafibrate, which is a pan-agonist of all PPAR-isoforms, might induce FALDH activity in human fibroblasts of control subjects and SLS patients that still have some residual FALDH activity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion evidence source_evidence_curated NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion SIO_000772 16837225 NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion wasDerivedFrom ctd_human-20130708 NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_assertion wasGeneratedBy ECO_0000218 NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP8417.RAPcu1omhG-vu4-BjgQdf-uYEnDsshyDZnxxBBk5W9xZ4130_provenance.